Quantcast

Neural Stem Cell Transplant May Tackle Diabetes

October 11, 2011

(Ivanhoe Newswire) — Time to start harvesting your own stem cells! A recent study shows that a new treatment for diabetes uses patients’ own stem cells can overcome a shortage of insulin-producing cells without the need for gene transfer.

Diabetes is caused by a lack of insulin production by the pancreas and affects more than 200 million people worldwide. There is currently no cure, leaving patients to rely on external supplies of insulin or treatments to alter levels of blood glucose.

The research, led by Dr. Tomoko Kuwabara from the Advanced Industrial Science and Technology Institute in Tsukuba, Japan, focused on developing methods for defining human stem cell differentiation, the process through which cells can be adapted to a specialized role, for use in cell replacement treatments.

“As diabetes is caused by the lack of a single type of cell the condition is an ideal target for cell replacement treatments,” Kuwabara was quoted as saying.

“However donation shortages of pancreatic beta cells are a major hurdle to advancing this treatment. So a safe and easy way of using stem cells for obtaining new beta cells has been long awaited.”

The hippocampus and olfactory bulb, at the front of the brain provide an easily accessible tissue source for cells that could be transplanted directly into the pancreas. Normally neuronal cells do not produce high levels of insulin, pancreatic cells do.

Insulin production increased in diabetic rats that received the cell transplants, along with reduced blood glucose levels and a display of key characteristics of pancreatic beta cells.

The removal of the transplant increased levels of blood glucose, revealing that transplanting neural stem cells into the pancreas could be an effective treatment for diabetes.

“The discovery of stem cells which have virtually unlimited self-renewal, raises great expectations for their use in regenerative medicine. The isolation and cultivation of stem cells as a renewable source of beta cells would be a major breakthrough,” wrote Onur Basak and Hans Clevers, from the Hubrecht Institute for Development Biology and Stem Cell Research, in their close up paper, published in the same issue of EMBO Molecular Medicine.

The study showed that neural stem cells can be obtained from a patient without the need for genetic manipulation and can be transplanted directly into the pancreas influencing the ability to regulate insulin production.

“Our findings demonstrate the potential value of neural stem cells for treating diabetes without gene transfer,” Kuwabara was quoted as saying. “This presents an original strategy to overcome the donor shortage which has hindered cell replacement therapy.”

SOURCE: EMBO Molecular Medicine, published online October 6, 2011




comments powered by Disqus